Androgen Receptor Dependence (Q92410955)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31900916 AND SRC:MED&resulttype=core&format=json

29 April 2020

review article

1 reference

title

Androgen Receptor Dependence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31900916 AND SRC:MED&resulttype=core&format=json

29 April 2020

author name string

Aashi P Chaturvedi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31900916 AND SRC:MED&resulttype=core&format=json

29 April 2020

Scott M Dehm

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31900916 AND SRC:MED&resulttype=core&format=json

29 April 2020

publication date

1 January 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31900916 AND SRC:MED&resulttype=core&format=json

Advances in Experimental Medicine and Biology

29 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31900916 AND SRC:MED&resulttype=core&format=json

29 April 2020

volume

1210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31900916 AND SRC:MED&resulttype=core&format=json

29 April 2020

page(s)

333-350

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31900916 AND SRC:MED&resulttype=core&format=json

Androgen receptor in prostate cancer

29 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Androgen receptor: structure, role in prostate cancer and drug discovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Interplay between two hormone-independent activation domains in the androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Identification of two transcription activation units in the N-terminal domain of the human androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Characterization of the two coactivator-interacting surfaces of the androgen receptor and their relative role in transcriptional control

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Alternatively spliced androgen receptor variants

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Molecular mechanisms of androgen receptor-mediated gene regulation: structure-function analysis of the AF-1 domain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Regulation of Androgen Receptor Activity by Transient Interactions of Its Transactivation Domain with General Transcription Regulators.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Androgen Receptor Splice Variants Dimerize to Transactivate Target Genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Structural basis of androgen receptor binding to selective androgen response elements.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Structure of the homodimeric androgen receptor ligand-binding domain

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

A surface on the androgen receptor that allosterically regulates coactivator binding

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Allosteric conversation in the androgen receptor ligand-binding domain surfaces.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Chemistry and structural biology of androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

31 March 2020

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Analysis of Interdomain Interactions of the Androgen Receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Serum testosterone levels after medical or surgical androgen deprivation: a comprehensive review of the literature

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Androgen Signaling in Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Steroid biosynthesis and prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Characterization of nuclear import of the domain-specific androgen receptor in association with the importin alpha/beta and Ran-guanosine 5'-triphosphate systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Androgen induces a switch from cytoplasmic retention to nuclear import of the androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Structural basis for the nuclear import of the human androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Comparing the rules of engagement of androgen and glucocorticoid receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Androgen receptor uses relaxed response element stringency for selective chromatin binding and transcriptional regulation in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Maintaining and reprogramming genomic androgen receptor activity in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

The androgen receptor malignancy shift in prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Unraveling the complexities of androgen receptor signaling in prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Aberrant BAF57 signaling facilitates prometastatic phenotypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

AR function in promoting metastatic prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

The Role of Hepatocyte Nuclear Factor-3α (Forkhead Box A1) and Androgen Receptor in Transcriptional Regulation of Prostatic Genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Gene regulatory mechanisms underpinning prostate cancer susceptibility

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

FOXA1 mutations in hormone-dependent cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

The mutational landscape of lethal castration-resistant prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Novel Androgen Receptor Coregulator GRHL2 Exerts Both Oncogenic and Antimetastatic Functions in Prostate Cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Endogenous androgen receptor proteomic profiling reveals genomic subcomplex involved in prostate tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Studies on Prostatic Cancer: I. The Effect of Castration, Of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Androgen receptor: past, present and future

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Outsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advanced prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Molecular determinants of resistance to antiandrogen therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

The Molecular Taxonomy of Primary Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

The evolutionary history of lethal metastatic prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Tumor clone dynamics in lethal prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Integrative genomic profiling of human prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Androgen receptor splice variants and prostate cancer: From bench to bedside

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Alternative splicing in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Androgen receptor variant-driven prostate cancer: clinical implications and therapeutic targeting

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Androgen Receptor Variant AR-V9 Is Coexpressed with AR-V7 in Prostate Cancer Metastases and Predicts Abiraterone Resistance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Assessment of the Validity of Nuclear-Localized Androgen Receptor Splice Variant 7 in Circulating Tumor Cells as a Predictive Biomarker for Castration-Resistant Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Integrative clinical genomics of advanced prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Posttranslational modification of the androgen receptor in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Androgen Receptor Splice Variants Activate Androgen Receptor Target Genes and Support Aberrant Prostate Cancer Cell Growth Independent of Canonical Androgen Receptor Nuclear Localization Signal

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

A transcription-independent function of FOXO1 in inhibition of androgen-independent activation of the androgen receptor in prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Crosstalk between the Androgen Receptor and PPAR Gamma Signaling Pathways in the Prostate.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

The role of peroxisome proliferator-activated receptor gamma in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

The Androgen Receptor Regulates PPARγ Expression and Activity in Human Prostate Cancer Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

A novel cutaneous Fatty Acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Vitamin K epoxide reductase regulation of androgen receptor activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Expression of peroxisome proliferator-activated receptor (PPAR) in human prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Androgen Receptor Rearrangement and Splicing Variants in Resistance to Endocrine Therapies in Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Increased survival with enzalutamide in prostate cancer after chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Abiraterone and increased survival in metastatic prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Inhibition of AKR1C3 Activation Overcomes Resistance to Abiraterone in Advanced Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Molecular Dynamics Studies on the Enzalutamide Resistance Mechanisms Induced by Androgen Receptor Mutations

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Chemical genetic control of protein levels: selective in vivo targeted degradation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

SGTA: a new player in the molecular co-chaperone game

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Targeting Binding Function-3 of the Androgen Receptor Blocks Its Co-Chaperone Interactions, Nuclear Translocation, and Activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

An androgen receptor N-terminal domain antagonist for treating prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Sintokamides A to E, chlorinated peptides from the sponge Dysidea sp. that inhibit transactivation of the N-terminus of the androgen receptor in prostate cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

EPI-001 is a selective peroxisome proliferator-activated receptor-gamma modulator with inhibitory effects on androgen receptor expression and activity in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Bypassing Drug Resistance Mechanisms of Prostate Cancer with Small Molecules that Target Androgen Receptor-Chromatin Interactions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-030-32656-2_15

10.1007/978-3-030-32656-2_15

31 March 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31900916 AND SRC:MED&resulttype=core&format=json

29 April 2020

1 reference